Stable Isotope Biogeochemistry of Seabird Guano Fertilization: Results from Growth Chamber Studies with Maize (Zea Mays)

Stable isotope analysis is being utilized with increasing regularity to examine a wide range of issues (diet, habitat use, migration) in ecology, geology, archaeology, and related disciplines. A crucial component to these studies is a thorough understanding of the range and causes of baseline isotopic variation, which is relatively poorly understood for nitrogen (δ(15)N). Animal excrement is known to impact plant δ(15)N values, but the effects of seabird guano have not been systematically studied from an agricultural or horticultural standpoint.This paper presents isotopic (δ(13)C and δ(15)N) and vital data for maize (Zea mays) fertilized with Peruvian seabird guano under controlled conditions. The level of (15)N enrichment in fertilized plants is very large, with δ(15)N values ranging between 25.5 and 44.7‰ depending on the tissue and amount of fertilizer applied; comparatively, control plant δ(15)N values ranged between -0.3 and 5.7‰. Intraplant and temporal variability in δ(15)N values were large, particularly for the guano-fertilized plants, which can be attributed to changes in the availability of guano-derived N over time, and the reliance of stored vs. absorbed N. Plant δ(13)C values were not significantly impacted by guano fertilization. High concentrations of seabird guano inhibited maize germination and maize growth. Moreover, high levels of seabird guano greatly impacted the N metabolism of the plants, resulting in significantly higher tissue N content, particularly in the stalk.The results presented in this study demonstrate the very large impact of seabird guano on maize δ(15)N values. The use of seabird guano as a fertilizer can thus be traced using stable isotope analysis in food chemistry applications (certification of organic inputs). Furthermore, the fertilization of maize with seabird guano creates an isotopic signature very similar to a high-trophic level marine resource, which must be considered when interpreting isotopic data from archaeological material

SATELLITE QUENCHING and GALACTIC CONFORMITY at 0.3 < z < 2.5

We measure the evolution of the quiescent fraction and quenching efficiency of satellites around star-forming and quiescent central galaxies with stellar mass at . We combine imaging from three deep near-infrared-selected surveys (ZFOURGE/CANDELS, Ultra Deep Survey, and UltraVISTA), which allows us to select a stellar-mass complete sample of satellites with . Satellites for both star-forming and quiescent central galaxies ("centrals") have higher quiescent fractions compared to field galaxies matched in stellar mass at all redshifts. We also observe "galactic conformity": satellites around quiescent centrals are more likely to be quenched compared to the satellites around star-forming centrals. In our sample, this conformity signal is significant at for , whereas it is only weakly significant at and . Therefore, conformity (and thus satellite quenching) has been present for a significant fraction of the age of the universe. The satellite quenching efficiency increases with increasing stellar mass of the central, but does not appear to depend on the stellar mass of the satellite to the mass limit of our sample. When we compare the satellite quenching efficiency of star-forming centrals with stellar masses 0.2 dex higher than quiescent centrals (which should account for any difference in halo mass), the conformity signal decreases, but remains statistically significant at . This is evidence that satellite quenching is connected to the star formation properties of the central galaxy as well as to the mass of the halo. We discuss physical effects that may contribute to galactic conformity, and emphasize that they must allow for continued star formation in the central galaxy even as the satellites are quenched

Complexity of Delivering Precision Medicine: Opportunities and Challenges

Precision medicine has emerged as a tool to match patients with the appropriate treatment based on the precise molecular features of an individual patient's tumor. Although examples of targeted therapies exist resulting in dramatic improvements in patient outcomes, comprehensive genomic profiling of tumors has also demonstrated the incredible complexity of molecular alterations in tissue and blood. These sequencing methods provide opportunities to study the landscape of tumors at baseline and serially in response to treatment. These tools also serve as important biomarkers to detect resistance to treatment and determine higher likelihood of responding to particular treatments, such as immune checkpoint blockade. Federally funded and publicly available data repositories have emerged as mechanisms for data sharing. In addition, novel clinical trials are emerging to develop new ways of incorporating molecular matched therapy into clinical trials. Various challenges to delivery of precision oncology include understanding the complexity of advanced tumors based on evolving "omics" and treatment resistance. For physicians, determining when and how to incorporate genetic and molecular tools into clinic in a cost-effective manner is critical. Finally, we discuss the importance of well-designed prospective clinical trials, biomarkers such as liquid biopsies, the use of multidisciplinary tumor boards, and data sharing as evidence-based medicine tools to optimally study and deliver precision oncology to our patients